The Certification That Matters More Than the Printer
On April 28, 2026, 3D Systems announced EU MDR Class IIa certification for its NextDent Jetted Denture Solution — the combination of NextDent Jet Base, NextDent Jet Teeth materials, and the NextDent 300 MultiJet printer. Commercial availability began May 4, two months ahead of the originally targeted summer launch (Company PR, April 28, 2026). The certification unlocks a European addressable market: the company estimates over 60 million edentulous patients across the US and EU represent a multi-billion dollar denture opportunity (Company PR, April 28, 2026).
This is not a story about hardware specs. The NextDent 300 has been on the market. The materials have been in development. What changed is the regulatory door swinging open — and in European medical AM right now, that door is the only one that matters.
Why Multi-Material Monolithic Changes the Denture Workflow
The technical differentiator in 3D Systems' solution is worth unpacking because it maps directly to lab economics. Stratasys' TrueDent, which achieved CE Class IIa certification on March 17, 2026, is a single-material system — the printer uses one resin to produce the entire denture, then relies on staining and characterization for aesthetic differentiation between gum base and teeth (3D Printing Industry, March 17, 2026).
3D Systems' MultiJet Printing (MJP) approach prints Jet Base and Jet Teeth materials in a single monolithic build cycle. No secondary curing. No manual assembly of teeth into a base. No post-processing step where a lab technician bonds separately printed components. The denture comes off the printer as one part, with two material properties distributed across the geometry.
For a dental lab evaluating digital workflow adoption, this collapses a multi-step manual process into a single print-and-finish cycle. The labor savings are not incremental — they restructure the lab's cost-per-denture line item. That is the kind of economic argument that converts a lab owner who has been milling PMMA blocks for fifteen years.
The Stratasys Precedent and the Six-Week Gap
Stratasys reached Class IIa first, but the comparison is not straightforward. TrueDent upgraded from Class I (self-declared, early 2025) to Class IIa (Notified Body reviewed) — a meaningful regulatory step, but one that kept the single-material workflow intact (3D Printing Industry, March 17, 2026). 3D Systems' certification covers a system with two distinct Class IIa materials and the printer as a combined solution, which required demonstrating that the multi-material interface — the bond between base and teeth materials — meets the same durability and biocompatibility standards as a monolithic single-material part.
The six-week gap between certifications means neither company holds regulatory exclusivity. Both are now competing on the same timeline to convert European dental labs. That competition will be won on workflow integration, training, distribution reach, and the speed at which labs can recoup their printer investment through per-case margins — not on who got the certificate first.
Prior Art: How the Dental AM Regulatory Race Escalated
This certification did not emerge from a vacuum. In February 2025, 3D Systems received FDA 510(k) clearance for the same NextDent Jetted Denture Solution in the US market — a clearance based on substantial equivalence to a predicate device. The EU MDR Class IIa pathway is structurally different: it requires independent third-party evaluation by a Notified Body under the more stringent Medical Device Regulation (MDR) 2017/745, which replaced the older Medical Device Directive (MDD) in 2021.
The company also obtained full-scope EU MDR certification in March 2026 — a broader quality-management-system certification that covers its manufacturing and design processes, not just the denture product itself (Company PR, April 28, 2026). That full-scope certification is the infrastructure layer underneath the product-specific Class IIa designation. Without it, the denture certification would not hold.
Smaller players have also navigated this path. Dentafab, a Turkish DLP manufacturer, received CE Class IIa certification for its PowerResins Temp and Denture materials in 2025 (3D Printing Industry). But Dentafab lacks the distribution network, application support team, and installed base of printers that 3D Systems and Stratasys can leverage across Europe. The certification-as-moat pattern applies across company sizes, but the moat's depth depends on what sits behind the certificate.
The Lab Conversion Problem — Why Certification Is Not Enough
The European denture market is fragmented across thousands of small dental laboratories. Many still use conventional compression molding or injection molding for denture fabrication. Converting these labs to a digital workflow requires more than a regulatory certificate — it requires capital expenditure on a printer, training for technicians, and a reliable supply chain for certified materials.
The counter-signal here is adoption velocity. Premium-priced digital workflows compete against established analog processes where lab owners already know their per-unit costs, their rejection rates, and their technician training requirements. A lab that produces 50 dentures per week on a compression-molding line has a known cost structure. Asking that lab to invest tens of thousands of euros in a printer, plus materials and training, requires a payback period that the OEM must demonstrate through case studies, not spec sheets.
Stratasys and 3D Systems will now compete on exactly this conversion metric. The winner will not be the company with the better certificate — it will be the company that builds the most effective on-ramp for a skeptical lab owner.
Regulatory Uncertainty as a Structural Risk
EU MDR implementation has been a moving target since the regulation took effect. The European Commission proposed a revision in December 2025 that could alter certification timelines, Notified Body capacity requirements, and transitional provisions (3D Printing Industry). Companies that invested early in full-scope MDR certification — as 3D Systems did in March 2026 — are betting that the regulatory framework stabilizes rather than shifts again.
If the Commission extends transitional periods or relaxes requirements for legacy devices, the competitive advantage of early certification diminishes. If it tightens requirements, the early movers gain a wider gap. Either way, the regulatory timeline is not fully under any OEM's control.
What Would Invalidate the Thesis
The thesis that EU MDR Class IIa certification is the primary competitive moat in European dental AM rests on three assumptions: that labs will adopt digital workflows at a meaningful rate, that the regulatory framework remains stable enough to protect early certifiers, and that the multi-material workflow advantage translates into measurable lab productivity gains.
The thesis breaks if:
- Lab conversion rates remain below 15% annually across the European market, indicating that analog workflows retain cost or quality advantages that digital cannot overcome.
- Stratasys or another competitor introduces a multi-material solution with Class IIa certification, eliminating 3D Systems' workflow differentiator.
- EU MDR revision materially alters the certification landscape, reducing the value of early investment.
None of these are imminent. But the next 12 months of European dental AM will be measured in lab adoption numbers, not press releases.